Economic and Social Disparities and Breast Cancer
- Conditions
- Breast Cancer
- Interventions
- Other: ExposedOther: Non exposed
- Registration Number
- NCT02948478
- Lead Sponsor
- Assistance Publique - H么pitaux de Paris
- Brief Summary
Precariousness is a multifactorial concept that can be broken down in the form of economic insecurity, and / or social insecurity and / or territorial insecurity. Precariousness has an impact on health that is difficult to assess precisely because it also impacts on other factors that may themselves influence health. Therefore, the understanding of the impact of precariousness on health involves studying individuals in their context.
Our study is designed to assess the impact of precariousness on the history of breast cancer, on care pathways, on treatment and rehabilitation in a multidisciplinary contextual analysis. Indeed, the socio -economic and geographical inequalities affect the history of breast cancer, treatment and its delay and post- treatment rehabilitation.
The main objective of this project is to compare the stage of disease at diagnosis (according to the TNM classification) in deprived and non deprived patients. The secondary objectives are to compare in the two groups - the socio-economic and geographical inequalities - the direct and indirect costs related to the management, the out-of pocket costs and to describe, based on individual inequalities identified, the pathway of care of the patient.
These objectives will be pursued in the framework of an observational cohort study, prospective, multicenter (Ile de France) comparative exposed / unexposed category. Each precarious patient will be matched to a non- precarious patient in the same age group, regardless of the center. The study will include any patient resident in Ile de France seeking treatment for breast cancer, regardless of the stage.
- Detailed Description
All patients seeking treatment for breast cancer, regardless of the stage, can be included in the study. Three scores of precariousness will be applied to all patients (EPICES score, Pascal score and the European Deprivation Index). Patients identified as precarious by at least one of those three scales will be in the exposed group. The others will be in the non-exposed group.
Baseline assessment T0:
Are required only the clinical examination and radiological evaluation with the tumor size and node involvement according to TNM classification. A questionnaire will be distributed including EPICES score, Pascal score and European Deprivation Index. The baseline questionnaire will also assess the socio-economic characteristics of patients and the care trajectory before arriving in the center (see appendix).
Follow-up visits:
The following questionnaire will be distributed during a consultation that is scheduled in the routine care. There will be no additional consultation imposed on the patient.
* T1: questionnaire at 3 months after inclusion
* T2: questionnaire at 6 months after inclusion
* T3: questionnaire at 12 months after inclusion
Questionnaires will be focused on direct-costs and out-of-pocket costs, socio-economical characteristics, rehabilitation, return to work.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 936
- Patients ? 18 years old having a breast cancer histologically proved
- Patients with a history of cancer treated in the previous five years, or with another associated untreated cancer
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Precarious patients Exposed Precarious patients - exposed - will be those identified as precarious by at least one of the three scores (EPICES, Pascal, European Deprivation Index) Non precarious patients Non exposed Non precarious patient - non exposed - will be all the patients identified as non-precarious by the three scores (EPICES, Pascal, European Deprivation Index)
- Primary Outcome Measures
Name Time Method TNM stage Baseline TNM classification according to initial clinical and radiological assessment
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (24)
Centre Hopitalier Victor Dupouy Argenteuil
馃嚝馃嚪Argenteuil, France
H么pital Jean Verdier
馃嚝馃嚪Bondy, France
Hopital Priv茅 Paule Egine
馃嚝馃嚪Champigny-sur-Marne, France
Centre Hospitalier de Pontoise
馃嚝馃嚪Cergy-Pontoise, France
CH Sud Francilien
馃嚝馃嚪Corbeil-Essonnes, France
Centre Hospitalier Intercommunal Cr茅teil
馃嚝馃嚪Creteil, France
H么pital Henri Mondor
馃嚝馃嚪Cr茅teil, France
Clinique Claude Bernard
馃嚝馃嚪Ermont, France
H么pital Bic锚tre
馃嚝馃嚪Le Kremlin-Bic锚tre, France
CH de Lagny sur Marne
馃嚝馃嚪Lagny-sur-Marne, France
Institut de Canc茅rologie Hartmann
馃嚝馃嚪Levallois-Perret, France
H么pital Saint-Louis
馃嚝馃嚪Paris, France
Institut Curie H么pital de Paris
馃嚝馃嚪Paris, France
H么pital Priv茅 des Peupliers
馃嚝馃嚪Paris, France
H么pital Tenon
馃嚝馃嚪Paris, France
HEGP
馃嚝馃嚪Paris, France
Groupe Hospitalier Paris Saint-Joseph
馃嚝馃嚪Paris, France
Institut de canc茅rologie Paris Nord
馃嚝馃嚪Sarcelles, France
Clinique de l'Estr茅e
馃嚝馃嚪Stains, France
Centre Hospitalier de Versailles
馃嚝馃嚪Versailles, France
Centre Hospitalier Intercommunal Poissy Saint Germain en Laye
馃嚝馃嚪Poissy, France
Institut Curie H么pital Ren茅-Huguenin site Saint-Cloud
馃嚝馃嚪Saint-Cloud, France
H么pital Lariboisi猫re
馃嚝馃嚪Paris, France
Centre Hospitalier Delafontaine
馃嚝馃嚪Saint-Denis, France